Delivery Order SPE2DB24D6041-SPE2DB25FKBPY

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of drospirenone-ee 3-0.02 mg tablets in 28-count packages. The contract has a ceiling value of $2,983.33 and a completion date of May 6, 2024. The contract was awarded on May 3, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), through a Delivery Order contract with a Firm Fixed Price pricing type. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,498.54 firm fixed-price delivery order is for the supply of pharmaceutical products, including the drug norethindrone-ethinyl estradiol 0.5-2.5 mg, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,582.93 firm fixed-price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets, a common oral contraceptive medication, with a period of performance through December 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,491.18 firm-fixed-price delivery order covers the supply of the drug Loestrin 21 1-20 tablet (21s) with a completion date of December 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,427.92 Firm Fixed Price Delivery Order is for the supply of 4566749445 - Junel FE 1 MG-20 MCG Tablet 28S, with an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,776.54 firm fixed-price delivery order covers the supply of 4566752087 ! SYEDA 28 TABLET 28S medical products, with a performance period through December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,401.92 firm fixed-price delivery order is for the supply of 4563796142 JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. The contract has a completion date of February 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.67 firm fixed-price delivery order is for the supply of Junel FE 1.5 mg-30 mcg tablets, a contraceptive medication. The contract has an ultimate completion date of January 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,040.16 firm fixed-price delivery order is for the supply of Loestrin FE 1.5-30 tablets, a contraceptive medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.84 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a completion date of July 15, 2024. The award is not designated as a set-aside contract. It is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBPY
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,622.76 firm fixed-price delivery order is for the supply of DROSPIRENONE-EE 3-0.02 MG TAB 28S pharmaceutical products, with a period of performance through January 14, 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There was no set-aside designation for this specific delivery order.

Generated 4/14/25, 10:25 AM